Skip to main content

TriaGen Wealth Management LLC

Position in ABBV — AbbVie Inc.

CIK 1843848 Calabasas, CA

Position in ABBV

as of Jun 30, 2026 · filed Jul 21, 2026
Position Value
$3,144,996
+$2,466,428 QoQ
Shares Held
12,498
+300.6% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
1.64%
of 13F equity value
Holder Rank
#1,626
of 4,153 holders
Holding Since
Dec 2020
23 quarters on record
Voting authority Sole 0% Shared 0% None 100%

Common Shares in ABBV Over Time

Shares Held

Position Value (USD)

Derivatives in ABBV

reported options exposure · as of Jun 30, 2026
CallValue
$553,608
CallShares
2,200
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Drug Manufacturers - General

Healthcare · as of Jun 30, 2026

TriaGen Wealth Management LLC holds $5,132,608 across 5 Drug Manufacturers - General names. ABBV ranks #1 (61.3% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ABBV
AbbVie Inc.
This page
12,498 $3,144,996

All Filings in ABBV

Export CSV
24 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $3,144,996 12,498
2026-06-30 $553,608 2,200
2026-03-31 $678,568 3,120
2025-12-31 $723,627 3,167
2025-09-30 $806,685 3,484
2025-06-30 $660,807 3,560
2025-03-31 $653,492 3,119
2024-12-31 $554,246 3,119
2024-09-30 $615,940 3,119
2024-06-30 $534,970 3,119
2024-03-31 $567,969 3,119
2023-12-31 $617,710 3,986
2023-09-30 $594,153 3,986
2023-06-30 $540,806 4,014
2023-03-31 $644,332 4,043
2022-12-31 $640,945 3,966
2022-09-30 $534,290 3,981
2022-06-30 $609,729 3,981
2022-03-31 $945,263 5,831
2021-12-31 $833,657 6,157
2021-09-30 $900,498 8,348
2021-06-30 $446,730 3,966
2021-03-31 $440,780 4,073
2020-12-31 $443,386 4,138